The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer

被引：0
作者：
Ming-Fang Wu
Chih-An Lin
Tzu-Hang Yuan
Hsiang-Yuan Yeh
Sheng-Fang Su
Chin-Lin Guo
Gee-Chen Chang
Ker-Chau Li
Chao-Chi Ho
Huei-Wen Chen
机构：
[1] National Taiwan University,Graduate Institute of Toxicology, College of Medicine
[2] Academia Sinica,Institute of Statistical Sciences
[3] National Taiwan University Hospital and National Taiwan University College of Medicine,Department of Internal Medicine
[4] National Taiwan University and Academia Sinica,Genome and Systems Biology Degree Program
[5] Soochow University,School of Big Data Management
[6] National Taiwan University College of Medicine,Graduate Institute of Oncology
[7] Academia Sinica,Institute of Physics
[8] Taichung Veterans General Hospital,Division of Chest Medicine, Department of Internal Medicine
[9] National Yang-Ming University,Faculty of Medicine, School of Medicine
[10] National Chung Hsing University,Institute of Biomedical Sciences
[11] Chung Shan Medical University Hospital,Division of Pulmonary Medicine, Department of Internal Medicine
[12] University of California,Department of Statistics
[13] Los Angeles,undefined
来源：
Cancer Immunology, Immunotherapy | 2021年 / 70卷
关键词：
Malignant pleural effusion; Macrophages; Lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1435 / 1450
页数：15
相关论文
共 179 条
  • [11] Bellipanni G(2011)Cancer-promoting tumor-associated macrophages: new vistas and open questions Eur J Immunol 41 2522-2525
  • [12] Macaluso M(2010)Macrophages, innate immunity and cancer: balance, tolerance, and diversity Curr Opin Immunol 22 231-237
  • [13] Mancini R(2016)Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: a systemic review and meta-analysis Oncotarget 7 34217-34228
  • [14] Holstein AC(2010)The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time BMC Cancer 10 112-976
  • [15] Milanese C(2015)CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion Cancer Immunol Immunother 64 965-10603
  • [16] Giovagnoli MR(2015)CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients Oncotarget 6 10592-5244
  • [17] Giordano A(2018)beta-glucans as potential immunoadjuvants: a review on the adjuvanticity, structure-activity relationship and receptor recognition properties Vaccine 36 5235-50
  • [18] Russo G(2009)Beta-glucan recognition by the innate immune system Immunol Rev 230 38-5065
  • [19] Li L(2015)Dectin-1 activation by a natural product beta-Glucan converts immunosuppressive macrophages into an M1-like phenotype J Immunol 195 5055-20
  • [20] Yang L(2014)Macrophage activation and polarization: nomenclature and experimental guidelines Immunity 41 14-1538
12345678910